Pandemic influenza A (H1N1) 2009 in Malaysia - The next phase

Medical Journal of Malaysia

Volumn 64, Issue 2, 2009, Pages 105-107

  Sam, Jamal I Cheng ^a   Abu Bakar, S ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; OSELTAMIVIR; ZANAMIVIR;

EDITORIAL; HIGH RISK POPULATION; HUMAN; INFECTION CONTROL; INFLUENZA; INFLUENZA VIRUS A H1N1; MALAYSIA; MIGRATION; NONHUMAN; PANDEMIC; VIRUS GENE; VIRUS STRAIN; ANIMAL; EPIDEMIC; SWINE; VIROLOGY;

ANIMALS; DISEASE OUTBREAKS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALAYSIA; SWINE;

EID: 77449147586     PISSN: 03005283     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (23)

1. World Health Organization. Situation updates - pandemic (H1N1) 2009. [Accessed 8 July 2009]. Available from: http://www.who.int/csr/disease/swineflu/ updates/en/index.html
2. Human infection with new influenza A (H1N1) virus: clinical observations from Mexico and other affected countries, May 2009. Wkly Epidemiol Rec 2009; 84: 185-9.
3. Health Protection Agency, Health Protection Scotland, National Public Health Service for Wales, HPA Northern Ireland Swine influenza investigation teams. Epidemiology of new influenza A (H1N1) virus infection, United Kingdom, April - June 2009. Euro Surveill 2009; 14: pii=19232. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19232
4. Chowell G, Bertozzi SM, Colchero MA, et al. Severe respiratory disease concurrent with the circulation of H1N1 influenza. N Engl J Med 2009; 361: doi: 10.1056/NEJMoa0904023. Epub 2009 Jun 29.
5. Centers for Disease Control and Prevention. Hospitalized patients with novel influenza A (H1N1) - California, April-May 2009. MMWR Morb Mortal Wkly Rep 2009; 58: 536-41.
6. Wilson N, Baker MG. The emerging influenza pandemic: estimating the case fatality ratio. Euro Surveill 2009; 14: pii=19255. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19255
7. Miller MA, Viboud C, Balinska M, Simonsen L. The signature features of influenza pandemics - implications for policy. N Engl J Med 2009; 360: 2595-8.
8. Centers for Disease Control and Prevention. Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. MMWR Morb Mortal Wkly Rep 2009; 58: 521-4.
9. Smith GJ, Vijaykrishna D, Bahl J, et al. Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature 2009; 459: 1122-5.
10. Zimmer SM, Burke DS. Historical perspective - emergence of influenza A (H1N1) viruses. N Engl J Med 2009; 361: 279-85.
11. Zhou NN, Senne DA, Landgraf JS, et al. Genetic reassortment of avian, swine, and human influenza A viruses in American pigs. J Virol 1999; 73: 8851-6.
12. Gorman OT, Bean WJ, Kawaoka Y, Donatelli I, Guo Y, Webster RG. Evolution of influenza A virus nucleoprotein genes: implications for the origins of H1N1 human and classical swine viruses. J Virol 1991; 65: 3704-14.
13. ProMED-mail. Influenza A (H1N1) - worldwide (80): Argentina, human to pig. ProMED-mail 2009; 1 Jul: 20090701.2376. 〈http://www.promedmail. org〉. Accessed 7 July 2009.
14. Ito T, Couceiro JNSS, Kelm S, et al. Molecular basis for the generation in pigs of influenza A viruses with pandemic potential. J Virol 1998; 72: 7367-73.
15. Myers KP, Olsen CW, Gray GC. Cases of swine influenza in humans: a review of the literature. Clin Infect Dis 2007; 44: 1084-8.
16. New influenza A (H1N1) virus: WHO guidance on public health measures, 11 June 2009. Wkly Epidemiol Rec 2009; 84: 261-8.
17. European Centre for Disease Prevention and Control. ECDC interim guidance: Mitigation and delaying (or 'containment') strategies as the new influenza A (H1N1) virus comes into Europe. Stockholm: ECDC, 2009.
18. ProMED-mail. Influenza A (H1N1) - worldwide (84): Tamiflu resistance, China (HK). ProMED-mail 2009; 6 Jul: 20090706.2428. 〈http://www.promedmail. org〉. Accessed 7 July 2009.
19. Hurt AC, Ernest J, Deng YM, et al. Emergence and spread of oseltamivir-resistant A (H1N1) influenza viruses in Oceania, South East Asia and South Africa. Antivir Res 2009; 83: 90-3.
20. Collin N, de Radiguès X, Kieny MP, the World Health Organization H1N1 Vaccine Task Force. New influenza A (H1N1) vaccine: how ready are we for large-scale production? Vaccine 2009; doi: 10.1016/j.vaccine.2009.06.034. Epub 2009 Jun 26.
21. Migliori GB, Sotgiu G, Lange C, Macgregor-Skinner G. Defining priorities: swine-origin H1N1 and the MDR-TB epidemic. Lancet 2009; 373: 2108.
22. Fraser C, Donnelly CA, Cauchemex S, et al. Pandemic potential of a strain of influenza A (H1N1): early findings. Science 2009; 324: 1557-61.
23. Global Influenza Programme, World Health Organisation. Pandemic influenza preparedness and response: a WHO guidance document. Geneva: WHO Press, 2009.